This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cirz, R. T.
Right arrow Articles by Romesberg, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cirz, R. T.
Right arrow Articles by Romesberg, F. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2006, p. 220-225, Vol. 50, No. 1
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.1.220-225.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Induction and Inhibition of Ciprofloxacin Resistance-Conferring Mutations in Hypermutator Bacteria

Ryan T. Cirz and Floyd E. Romesberg*

Department of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, California 92037

Received 13 May 2005/ Returned for modification 1 August 2005/ Accepted 12 September 2005

The emergence of drug-resistant bacteria poses a serious threat to human health. Bacteria often acquire resistance from a mutation of chromosomal genes during therapy. We have recently shown that the evolution of resistance to ciprofloxacin in vivo and in vitro requires the induction of a mutation that is mediated by the cleavage of the SOS repressor LexA and the associated derepression of three specialized DNA polymerases (polymerase II [Pol II], Pol IV, and Pol V). These results led us to suggest that it may be possible to design drugs to inhibit these proteins and that such drugs might be coadministered with antibiotics to prevent mutation and the evolution of resistance. For the approach to be feasible, there must not be any mechanisms through which bacteria can induce mutations and acquire antibiotic resistance that are independent of LexA and its repressed polymerases. Perhaps the most commonly cited mechanism to elevate bacterial mutation rates is the inactivation of methyl-directed mismatch repair (MMR). However, it is unclear whether this represents a LexA-independent mechanism or if the mutations that arise in MMR-deficient hypermutator strains are also dependent on LexA cleavage and polymerase derepression. In this work, we show that LexA cleavage and polymerase derepression are required for the evolution of clinically significant resistance in MMR-defective Escherichia coli. Thus, drugs that inhibit the proteins responsible for induced mutations are expected to efficiently prevent the evolution of resistance, even in MMR-deficient hypermutator strains.

* Corresponding author. Mailing address: Department of Chemistry,The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 784-7290. Fax: (858) 784-7472. E-mail: floyd{at}scripps.edu.

Antimicrobial Agents and Chemotherapy, January 2006, p. 220-225, Vol. 50, No. 1
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.1.220-225.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Heisig, P. (2009). Type II topoisomerases--inhibitors, repair mechanisms and mutations. Mutagenesis 24: 465-469 [Abstract] [Full Text]  
  • Lopez, E., Blazquez, J. (2009). Effect of Subinhibitory Concentrations of Antibiotics on Intrachromosomal Homologous Recombination in Escherichia coli. Antimicrob. Agents Chemother. 53: 3411-3415 [Abstract] [Full Text]  
  • Shurtleff, B. W., Ollivierre, J. N., Tehrani, M., Walker, G. C., Beuning, P. J. (2009). Steric Gate Variants of UmuC Confer UV Hypersensitivity on Escherichia coli. J. Bacteriol. 191: 4815-4823 [Abstract] [Full Text]  
  • Wang, M., Jacoby, G. A., Mills, D. M., Hooper, D. C. (2009). SOS Regulation of qnrB Expression. Antimicrob. Agents Chemother. 53: 821-823 [Abstract] [Full Text]  
  • Morgan-Linnell, S. K., Becnel Boyd, L., Steffen, D., Zechiedrich, L. (2009). Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical Isolates. Antimicrob. Agents Chemother. 53: 235-241 [Abstract] [Full Text]  
  • Mesak, L. R., Miao, V., Davies, J. (2008). Effects of Subinhibitory Concentrations of Antibiotics on SOS and DNA Repair Gene Expression in Staphylococcus aureus. Antimicrob. Agents Chemother. 52: 3394-3397 [Abstract] [Full Text]  
  • Bacher, J. M., Schimmel, P. (2007). An editing-defective aminoacyl-tRNA synthetase is mutagenic in aging bacteria via the SOS response. Proc. Natl. Acad. Sci. USA 104: 1907-1912 [Abstract] [Full Text]  
  • Cirz, R. T., Jones, M. B., Gingles, N. A., Minogue, T. D., Jarrahi, B., Peterson, S. N., Romesberg, F. E. (2007). Complete and SOS-Mediated Response of Staphylococcus aureus to the Antibiotic Ciprofloxacin. J. Bacteriol. 189: 531-539 [Abstract] [Full Text]  
  • Cirz, R. T., O'Neill, B. M., Hammond, J. A., Head, S. R., Romesberg, F. E. (2006). Defining the Pseudomonas aeruginosa SOS Response and Its Role in the Global Response to the Antibiotic Ciprofloxacin.. J. Bacteriol. 188: 7101-7110 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»